Law & Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law & Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Biopharmaceuticals
XTL Biopharmaceuticals Announces Appointment of Samuel H. Rudman to Board of Directors
August 30th, 2008
XTL Biopharmaceuticals Ltd. (NASDAQ:XTLB) announced that Samuel H. Rudman, Esq., has been appointed to XTL's Board of Directors, effective as of August 13, 2008. Mr. Rudman, 40, is a named partner at a U.S. law firm specializing in complex litigation, emphasizing securities, consumer, insurance, healthcare, human rights, employment discrimination and antitrust class actions. Mr. Rudman's practice is focused primarily on the area of securities and shareholder litigation, and complex issues of disclosure and corporate governance. Mr. Rudman graduated with a BA in political science from Binghamton University and with a JD from Brooklyn Law...
Source: Law & Health Weekly (2008-08-30)
|
